These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30108161)

  • 1. Tamoxifen Directly Interacts with the Dopamine Transporter.
    Mikelman SR; Guptaroy B; Schmitt KC; Jones KT; Zhen J; Reith MEA; Gnegy ME
    J Pharmacol Exp Ther; 2018 Oct; 367(1):119-128. PubMed ID: 30108161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct and Systemic Administration of a CNS-Permeant Tamoxifen Analog Reduces Amphetamine-Induced Dopamine Release and Reinforcing Effects.
    Carpenter C; Zestos AG; Altshuler R; Sorenson RJ; Guptaroy B; Showalter HD; Kennedy RT; Jutkiewicz E; Gnegy ME
    Neuropsychopharmacology; 2017 Sep; 42(10):1940-1949. PubMed ID: 28492278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a Novel Allosteric Modulator of the Human Dopamine Transporter.
    Aggarwal S; Liu X; Rice C; Menell P; Clark PJ; Paparoidamis N; Xiao YC; Salvino JM; Fontana ACK; España RA; Kortagere S; Mortensen OV
    ACS Chem Neurosci; 2019 Aug; 10(8):3718-3730. PubMed ID: 31184115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of MDPV on dopamine transporter regulation in male rats. Comparison with cocaine.
    Lopez-Arnau R; Duart-Castells L; Aster B; Camarasa J; Escubedo E; Pubill D
    Psychopharmacology (Berl); 2019 Mar; 236(3):925-938. PubMed ID: 30284596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 Tat protein-induced rapid and reversible decrease in [3H]dopamine uptake: dissociation of [3H]dopamine uptake and [3H]2beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane (WIN 35,428) binding in rat striatal synaptosomes.
    Zhu J; Mactutus CF; Wallace DR; Booze RM
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1071-83. PubMed ID: 19325033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid delivery of the dopamine transporter to the plasmalemmal membrane upon amphetamine stimulation.
    Johnson LA; Furman CA; Zhang M; Guptaroy B; Gnegy ME
    Neuropharmacology; 2005 Nov; 49(6):750-8. PubMed ID: 16212991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 transgenic rats display an increase in [(3)H]dopamine uptake in the prefrontal cortex and striatum.
    Zhu J; Yuan Y; Midde NM; Gomez AM; Sun WL; Quizon PM; Zhan CG
    J Neurovirol; 2016 Jun; 22(3):282-92. PubMed ID: 26501780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mice expressing markedly reduced striatal dopamine transporters exhibit increased locomotor activity, dopamine uptake turnover rate, and cocaine responsiveness.
    Rao A; Sorkin A; Zahniser NR
    Synapse; 2013 Oct; 67(10):668-77. PubMed ID: 23564231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined in vitro and in silico approaches to the assessment of stimulant properties of novel psychoactive substances - The case of the benzofuran 5-MAPB.
    Sahai MA; Davidson C; Khelashvili G; Barrese V; Dutta N; Weinstein H; Opacka-Juffry J
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Apr; 75():1-9. PubMed ID: 27890676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulator of G protein signaling-12 modulates the dopamine transporter in ventral striatum and locomotor responses to psychostimulants.
    Gross JD; Kaski SW; Schroer AB; Wix KA; Siderovski DP; Setola V
    J Psychopharmacol; 2018 Feb; 32(2):191-203. PubMed ID: 29364035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane-permeable C-terminal dopamine transporter peptides attenuate amphetamine-evoked dopamine release.
    Rickhag M; Owens WA; Winkler MT; Strandfelt KN; Rathje M; Sørensen G; Andresen B; Madsen KL; Jørgensen TN; Wörtwein G; Woldbye DPD; Sitte H; Daws LC; Gether U
    J Biol Chem; 2013 Sep; 288(38):27534-27544. PubMed ID: 23884410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine transporter phosphorylation site threonine 53 is stimulated by amphetamines and regulates dopamine transport, efflux, and cocaine analog binding.
    Challasivakanaka S; Zhen J; Smith ME; Reith MEA; Foster JD; Vaughan RA
    J Biol Chem; 2017 Nov; 292(46):19066-19075. PubMed ID: 28939767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relations between stimulation of mesolimbic dopamine and place conditioning in rats produced by cocaine or drugs that are tolerant to dopamine transporter conformational change.
    Tanda G; Li SM; Mereu M; Thomas AM; Ebbs AL; Chun LE; Tronci V; Green JL; Zou MF; Kopajtic TA; Newman AH; Katz JL
    Psychopharmacology (Berl); 2013 Sep; 229(2):307-21. PubMed ID: 23612854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dopamine transporter expression level differentially affects responses to cocaine and amphetamine.
    Cagniard B; Sotnikova TD; Gainetdinov RR; Zhuang X
    J Neurogenet; 2014; 28(1-2):112-21. PubMed ID: 24673634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low and high cocaine locomotor responding male Sprague-Dawley rats differ in rapid cocaine-induced regulation of striatal dopamine transporter function.
    Mandt BH; Zahniser NR
    Neuropharmacology; 2010 Mar; 58(3):605-12. PubMed ID: 19951714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of the biogenic amine transporters 15. Identification of novel allosteric dopamine transporter ligands with nanomolar potency.
    Rothman RB; Ananthan S; Partilla JS; Saini SK; Moukha-Chafiq O; Pathak V; Baumann MH
    J Pharmacol Exp Ther; 2015 Jun; 353(3):529-38. PubMed ID: 25788711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-dioxin-like PCBs inhibit [(3)H]WIN-35,428 binding to the dopamine transporter: a structure-activity relationship study.
    Wigestrand MB; Stenberg M; Walaas SI; Fonnum F; Andersson PL
    Neurotoxicology; 2013 Dec; 39():18-24. PubMed ID: 23933243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemistry and pharmacology of the piperidine-based analogues of cocaine. Identification of potent DAT inhibitors lacking the tropane skeleton.
    Kozikowski AP; Araldi GL; Boja J; Meil WM; Johnson KM; Flippen-Anderson JL; George C; Saiah E
    J Med Chem; 1998 May; 41(11):1962-9. PubMed ID: 9599245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter.
    Pifl C; Drobny H; Reither H; Hornykiewicz O; Singer EA
    Mol Pharmacol; 1995 Feb; 47(2):368-73. PubMed ID: 7870046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin-dependent kinase 5 inhibitors: inhibition of dopamine transporter activity.
    Price DA; Sorkin A; Zahniser NR
    Mol Pharmacol; 2009 Oct; 76(4):812-23. PubMed ID: 19628755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.